Today's Pre-Market Movers and Top Ratings | NVO, TSLA, TRAW and More

$Novo-Nordisk A/S (NVO.US)$ shares rose 5%, recovering from an 18% drop in the previous session after its weight loss drug, CagriSema, posted disappointing late-stage trial results on Friday.

$Tesla (TSLA.US)$ gained 3% premarket, recovering from last week's 3.5% drop, its worst performance since before the U.S. presidential election.

$Traws Pharma (TRAW.US)$ shares surged 109% after announcing progress on its H5N1 bird flu treatment. Its drug, tivoxavir marboxil, showed safety in phase 1 trials, with phase 2 set to start early next year amid rising bird flu concerns.

$Despegar.com (DESP.US)$ shares jumped 32% after Prosus agreed to acquire the online travel platform for $19.50 per share in a $1.7 billion deal set to close in Q2 2025.

$Qualcomm (QCOM.US)$ stock gained 2.8% after a jury upheld its central processors as properly licensed under an agreement with $Arm Holdings (ARM.US)$, whose stock fell 2.4%.